Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for Persistent Diabetic Vitreous Haemorrhage
NCT01030770Phase 3Completed
- Sponsor
- King's College Hospital
- Start
- Jul 2010
- Primary completion
- Dec 2015
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ranibizumab in vitreous hemorrhage secondary to proliferative diabetic retinopathy (DVH), sponsored by King's College Hospital. Started Jul 2010; status: completed.
02
Drugs
ranibizumab
03
Conditions
vitreous hemorrhage secondary to proliferative diabetic retinopathy (DVH)
Beyond the preview
Go deeper on NCT01030770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01030770.